{"entity":{"type":"insider","cik":"0001673277","url":"/insider/0001673277","json_url":"/insider/0001673277.json","name":"Francis Richard D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2017-11-24","last":"2026-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Francis Richard D","source":"filing","n_filings":11,"first_seen":"2017-11-24","last_seen":"2026-06-08"}],"transactions":[{"id":6116813,"accession":"0001193125-26-261660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-261660","line_url":"/filing/0001193125-26-261660#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6153.0,"shares_display":"6,153","price_per_share":34.35,"price_display":"34.35","price_state":"stated","total_value":211355.55,"total_display":"211,355.55","shares_owned_after":1177529.0,"shares_owned_after_display":"1,177,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-08","scope":"insider"},{"id":5958916,"accession":"0001193125-26-098551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-098551","line_url":"/filing/0001193125-26-098551#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20025.0,"shares_display":"20,025","price_per_share":31.6684,"price_display":"31.67","price_state":"stated","total_value":634159.71,"total_display":"634,159.71","shares_owned_after":1170639.0,"shares_owned_after_display":"1,170,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":5929807,"accession":"0001193125-26-096591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-096591","line_url":"/filing/0001193125-26-096591#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23393.0,"shares_display":"23,393","price_per_share":32.4645,"price_display":"32.46","price_state":"stated","total_value":759442.0485,"total_display":"759,442.05","shares_owned_after":1148212.0,"shares_owned_after_display":"1,148,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":5822596,"accession":"0001193125-26-093916","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-093916","line_url":"/filing/0001193125-26-093916#line-4","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412032.0,"shares_display":"412,032","price_per_share":32.3599,"price_display":"32.36","price_state":"stated","total_value":13333314.3168,"total_display":"13,333,314.32","shares_owned_after":1121382.0,"shares_owned_after_display":"1,121,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider"},{"id":5822592,"accession":"0001193125-26-093916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-093916","line_url":"/filing/0001193125-26-093916#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30903.0,"shares_display":"30,903","price_per_share":32.3599,"price_display":"32.36","price_state":"stated","total_value":1000017.9897,"total_display":"1,000,017.99","shares_owned_after":642099.0,"shares_owned_after_display":"642,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider"},{"id":6016280,"accession":"0001193125-26-056996","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-056996","line_url":"/filing/0001193125-26-056996#line-4","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":286122.0,"shares_display":"286,122","price_per_share":34.2241,"price_display":"34.22","price_state":"stated","total_value":9792267.9402,"total_display":"9,792,267.94","shares_owned_after":605771.0,"shares_owned_after_display":"605,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-15","filed_date":"2026-02-18","scope":"insider"},{"id":6016277,"accession":"0001193125-26-056996","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-056996","line_url":"/filing/0001193125-26-056996#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161656.0,"shares_display":"161,656","price_per_share":34.2241,"price_display":"34.22","price_state":"stated","total_value":5532531.1096,"total_display":"5,532,531.11","shares_owned_after":271783.0,"shares_owned_after_display":"271,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-15","filed_date":"2026-02-18","scope":"insider"},{"id":4616234,"accession":"0000950170-25-034583","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-034583","line_url":"/filing/0000950170-25-034583#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8259.0,"shares_display":"8,259","price_per_share":15.9132,"price_display":"15.91","price_state":"stated","total_value":131427.1188,"total_display":"131,427.12","shares_owned_after":271783.0,"shares_owned_after_display":"271,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4616232,"accession":"0000950170-25-034583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-034583","line_url":"/filing/0000950170-25-034583#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15514.0,"shares_display":"15,514","price_per_share":15.7346,"price_display":"15.73","price_state":"stated","total_value":244106.5844,"total_display":"244,106.58","shares_owned_after":280042.0,"shares_owned_after_display":"280,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":4164150,"accession":"0000950170-25-033515","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-033515","line_url":"/filing/0000950170-25-033515#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6450.0,"shares_display":"6,450","price_per_share":15.5576,"price_display":"15.56","price_state":"stated","total_value":100346.52,"total_display":"100,346.52","shares_owned_after":245333.0,"shares_owned_after_display":"245,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":4164145,"accession":"0000950170-25-033515","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033515","line_url":"/filing/0000950170-25-033515#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24892.0,"shares_display":"24,892","price_per_share":16.1855,"price_display":"16.19","price_state":"stated","total_value":402889.466,"total_display":"402,889.47","shares_owned_after":251783.0,"shares_owned_after_display":"251,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4416203,"accession":"0000950170-25-023126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-023126","line_url":"/filing/0000950170-25-023126#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75506.0,"shares_display":"75,506","price_per_share":16.9478,"price_display":"16.95","price_state":"stated","total_value":1279660.5868,"total_display":"1,279,660.59","shares_owned_after":209444.0,"shares_owned_after_display":"209,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":3108774,"accession":"0000950170-24-026008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-026008","line_url":"/filing/0000950170-24-026008#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31061.0,"shares_display":"31,061","price_per_share":13.3373,"price_display":"13.34","price_state":"stated","total_value":414269.8753,"total_display":"414,269.88","shares_owned_after":123295.0,"shares_owned_after_display":"123,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":2036863,"accession":"0000950170-24-016803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-016803","line_url":"/filing/0000950170-24-016803#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74530.0,"shares_display":"74,530","price_per_share":13.1514,"price_display":"13.15","price_state":"stated","total_value":980173.842,"total_display":"980,173.84","shares_owned_after":87125.0,"shares_owned_after_display":"87,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":4155485,"accession":"0001515622-17-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001515622-17-000088","line_url":"/filing/0001515622-17-000088#line-1","is_derivative":false,"issuer_cik":"0001037646","issuer_name":"METTLER TOLEDO INTERNATIONAL INC/","issuer_ticker":"MTD","issuer_name_source":null,"issuer_url":"/issuer/0001037646","owner_cik":"0001673277","owner_name":"Francis Richard D","owner_url":"/insider/0001673277","role":"Director","officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160.0,"shares_display":"160","price_per_share":627.91,"price_display":"627.91","price_state":"stated","total_value":100465.6,"total_display":"100,465.60","shares_owned_after":254.0,"shares_owned_after_display":"254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-17","filed_date":"2017-11-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (President and CEO)","n_filings":10,"first_seen":"2024-02-20","last_seen":"2026-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001037646","name":"METTLER TOLEDO INTERNATIONAL INC/","url":"/issuer/0001037646","role":"Director","n_filings":1,"first_seen":"2017-11-24","last_seen":"2017-11-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673277","retrieved_at":"2026-08-21T14:55:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}